Soft tissue sarcoma of the head and neck in childhood: Nonorbital and nonparameningeal sites a report of the intergroup rhabdomyosarcoma study (IRS)‐I

Moody D. Wharam, Mary A. Foulkes, Walter Lawrence, Robert D. Lindberg, Harold M. Maurer, William A. Newton, Abdelsalam H. Ragab, R. Beverly Raney, Melvin Tefft

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Seventy‐two patients with soft tissue sarcoma arising in the oral cavity, oropharynx, larynx, parotid region, cheek, scalp, and neck, were entered on the Intergroup Rhabdomyosarcoma Study (IRS)‐I, and could be analyzed for survival. Sixty‐three (88%) attained complete remission (CR), of whom 13 subsequently relapsed (78% actuarial 5‐year retained CR rate). The patients with primary tumor arising in sites other than the neck had a retained CR rate exceeding 90%. In contrast, 11 relapses occurred in the 26 patients with neck primaries (54% retained CR rate). Females, and infants younger than age 24 months were more likely to relapse. Prognostic factors with little or no influence on relapse included tumor size, histology, regional lymph node status, clinical group, and treatment arm. Five of the 6 patients with failure at the primary site had either no radiotherapy (2 patients) or an insufficient dose (<3000 rad). No patient required major organ sacrifice such as laryngectomy or pharyngectomy. Isolated failure in regional nodes did not occur. Children with nonorbital, nonparameningeal head and neck soft tissue sarcoma treated in accordance with the IRS protocol have an excellent rate of local control and survival. Primary tumors arising in the neck are more likely to relapse locally or distantly.

Original languageEnglish (US)
Pages (from-to)1016-1019
Number of pages4
JournalCancer
Volume53
Issue number4
DOIs
StatePublished - Feb 15 1984

Fingerprint

Rhabdomyosarcoma
Sarcoma
Neck
Head
Recurrence
Pharyngectomy
Parotid Region
Neoplasms
Oropharynx
Laryngectomy
Survival
Cheek
Larynx
Scalp
Mouth
Histology
Arm
Radiotherapy
Lymph Nodes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Soft tissue sarcoma of the head and neck in childhood : Nonorbital and nonparameningeal sites a report of the intergroup rhabdomyosarcoma study (IRS)‐I. / Wharam, Moody D.; Foulkes, Mary A.; Lawrence, Walter; Lindberg, Robert D.; Maurer, Harold M.; Newton, William A.; Ragab, Abdelsalam H.; Raney, R. Beverly; Tefft, Melvin.

In: Cancer, Vol. 53, No. 4, 15.02.1984, p. 1016-1019.

Research output: Contribution to journalArticle

Wharam, Moody D. ; Foulkes, Mary A. ; Lawrence, Walter ; Lindberg, Robert D. ; Maurer, Harold M. ; Newton, William A. ; Ragab, Abdelsalam H. ; Raney, R. Beverly ; Tefft, Melvin. / Soft tissue sarcoma of the head and neck in childhood : Nonorbital and nonparameningeal sites a report of the intergroup rhabdomyosarcoma study (IRS)‐I. In: Cancer. 1984 ; Vol. 53, No. 4. pp. 1016-1019.
@article{41d4552101644c8c8691eeacc14aa8a2,
title = "Soft tissue sarcoma of the head and neck in childhood: Nonorbital and nonparameningeal sites a report of the intergroup rhabdomyosarcoma study (IRS)‐I",
abstract = "Seventy‐two patients with soft tissue sarcoma arising in the oral cavity, oropharynx, larynx, parotid region, cheek, scalp, and neck, were entered on the Intergroup Rhabdomyosarcoma Study (IRS)‐I, and could be analyzed for survival. Sixty‐three (88{\%}) attained complete remission (CR), of whom 13 subsequently relapsed (78{\%} actuarial 5‐year retained CR rate). The patients with primary tumor arising in sites other than the neck had a retained CR rate exceeding 90{\%}. In contrast, 11 relapses occurred in the 26 patients with neck primaries (54{\%} retained CR rate). Females, and infants younger than age 24 months were more likely to relapse. Prognostic factors with little or no influence on relapse included tumor size, histology, regional lymph node status, clinical group, and treatment arm. Five of the 6 patients with failure at the primary site had either no radiotherapy (2 patients) or an insufficient dose (<3000 rad). No patient required major organ sacrifice such as laryngectomy or pharyngectomy. Isolated failure in regional nodes did not occur. Children with nonorbital, nonparameningeal head and neck soft tissue sarcoma treated in accordance with the IRS protocol have an excellent rate of local control and survival. Primary tumors arising in the neck are more likely to relapse locally or distantly.",
author = "Wharam, {Moody D.} and Foulkes, {Mary A.} and Walter Lawrence and Lindberg, {Robert D.} and Maurer, {Harold M.} and Newton, {William A.} and Ragab, {Abdelsalam H.} and Raney, {R. Beverly} and Melvin Tefft",
year = "1984",
month = "2",
day = "15",
doi = "10.1002/1097-0142(19840215)53:4<1016::AID-CNCR2820530432>3.0.CO;2-2",
language = "English (US)",
volume = "53",
pages = "1016--1019",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Soft tissue sarcoma of the head and neck in childhood

T2 - Nonorbital and nonparameningeal sites a report of the intergroup rhabdomyosarcoma study (IRS)‐I

AU - Wharam, Moody D.

AU - Foulkes, Mary A.

AU - Lawrence, Walter

AU - Lindberg, Robert D.

AU - Maurer, Harold M.

AU - Newton, William A.

AU - Ragab, Abdelsalam H.

AU - Raney, R. Beverly

AU - Tefft, Melvin

PY - 1984/2/15

Y1 - 1984/2/15

N2 - Seventy‐two patients with soft tissue sarcoma arising in the oral cavity, oropharynx, larynx, parotid region, cheek, scalp, and neck, were entered on the Intergroup Rhabdomyosarcoma Study (IRS)‐I, and could be analyzed for survival. Sixty‐three (88%) attained complete remission (CR), of whom 13 subsequently relapsed (78% actuarial 5‐year retained CR rate). The patients with primary tumor arising in sites other than the neck had a retained CR rate exceeding 90%. In contrast, 11 relapses occurred in the 26 patients with neck primaries (54% retained CR rate). Females, and infants younger than age 24 months were more likely to relapse. Prognostic factors with little or no influence on relapse included tumor size, histology, regional lymph node status, clinical group, and treatment arm. Five of the 6 patients with failure at the primary site had either no radiotherapy (2 patients) or an insufficient dose (<3000 rad). No patient required major organ sacrifice such as laryngectomy or pharyngectomy. Isolated failure in regional nodes did not occur. Children with nonorbital, nonparameningeal head and neck soft tissue sarcoma treated in accordance with the IRS protocol have an excellent rate of local control and survival. Primary tumors arising in the neck are more likely to relapse locally or distantly.

AB - Seventy‐two patients with soft tissue sarcoma arising in the oral cavity, oropharynx, larynx, parotid region, cheek, scalp, and neck, were entered on the Intergroup Rhabdomyosarcoma Study (IRS)‐I, and could be analyzed for survival. Sixty‐three (88%) attained complete remission (CR), of whom 13 subsequently relapsed (78% actuarial 5‐year retained CR rate). The patients with primary tumor arising in sites other than the neck had a retained CR rate exceeding 90%. In contrast, 11 relapses occurred in the 26 patients with neck primaries (54% retained CR rate). Females, and infants younger than age 24 months were more likely to relapse. Prognostic factors with little or no influence on relapse included tumor size, histology, regional lymph node status, clinical group, and treatment arm. Five of the 6 patients with failure at the primary site had either no radiotherapy (2 patients) or an insufficient dose (<3000 rad). No patient required major organ sacrifice such as laryngectomy or pharyngectomy. Isolated failure in regional nodes did not occur. Children with nonorbital, nonparameningeal head and neck soft tissue sarcoma treated in accordance with the IRS protocol have an excellent rate of local control and survival. Primary tumors arising in the neck are more likely to relapse locally or distantly.

UR - http://www.scopus.com/inward/record.url?scp=0021342427&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021342427&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(19840215)53:4<1016::AID-CNCR2820530432>3.0.CO;2-2

DO - 10.1002/1097-0142(19840215)53:4<1016::AID-CNCR2820530432>3.0.CO;2-2

M3 - Article

C2 - 6692285

AN - SCOPUS:0021342427

VL - 53

SP - 1016

EP - 1019

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -